A systematic review of tacrolimus ointment compared with corticosteroids in the treatment of atopic dermatitis

References

• Hoare C, Li Wan Po A, Williams H. Systematic review of treatments for atopic eczema. Health Technol Assess 2000;4:1-191
   PubMedGoogle Scholar
• Leung DY, Bieber T. Atopic dermatitis. Lancet 2003;361:151-60
   PubMed Web of Science ®Google Scholar
• Flohr C, Pascoe D, Williams HC. Atopic dermatitis and the ‘hygiene hypothesis’: too clean to be true? Br J Dermatol 2005;152:202-16
   PubMed Web of Science ®Google Scholar
• Bisgaard H, Simpson A, Palmer CN, et al. Gene-environment interaction in the onset of eczema in infancy: filaggrin loss-of-function mutations enhanced by neonatal cat exposure. PLoS Med 2008;5:e131
   PubMed Web of Science ®Google Scholar
• van den Oord RA, Sheikh A. Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders: systematic review and meta-analysis. BMJ 2009;339:b2433
   PubMed Web of Science ®Google Scholar
• Cork MJ, Danby SG, Vasilopoulos Y, et al. Epidermal barrier dysfunction in atopic dermatitis. J Invest Dermatol 2009;129:1892-908
   PubMed Web of Science ®Google Scholar
• Williams H, Stewart A, von Mutius E, et al. Is eczema really on the increase worldwide? J Allergy Clin Immunol 2008;121:947-54 e15
   PubMed Web of Science ®Google Scholar
• Harrop J, Chinn S, Verlato G, et al. Eczema, atopy and allergen exposure in adults: a population-based study. Clin Exp Allergy 2007;37:526-35
   PubMed Web of Science ®Google Scholar
• Charman C, Williams HC. Epidemiology. In: Bieber T, Leung DYM, eds. Atopic Dermatitis, 1st edn. New York: Marcel Dekker, 2002:21-42
   Google Scholar
• Emerson RM, Williams HC, Allen BR. Severity distribution of atopic dermatitis in the community and its relationship to secondary referral. Br J Dermatol 1998;139:73-6
   PubMed Web of Science ®Google Scholar
• Williams HC. Established corticosteroid creams should be applied only once daily in patients with atopic eczema. BMJ 2007;334:1272
   PubMed Web of Science ®Google Scholar
• Reitamo S, Van Leent EJM, Ho V, et al. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis. J Allergy Clin Immunol 2002;109:539-46
   PubMed Web of Science ®Google Scholar
• Kapp A, Papp K, Bingham A, et al. Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug. J Allergy Clin Immunol 2002;110:277-84
   PubMed Web of Science ®Google Scholar
• Hebert AA, Warken KA, Cherill R. Pimecrolimus cream 1%: a new development in nonsteroid topical treatment of inflammatory skin diseases. Semin Cutan Med Surg 2001;20:260-7
   PubMed Web of Science ®Google Scholar
• Charman CR, Morris AD, Williams HC. Topical corticosteroid phobia in patients with atopic eczema. Br J Dermatol 2000;142:931-6
   PubMed Web of Science ®Google Scholar
• Williams H. New treatments for atopic dermatitis. BMJ 2002;324:1533-4
   PubMed Web of Science ®Google Scholar
• Remitz A, Reitamo S. Long-term safety of tacrolimus ointment in atopic dermatitis. Expert Opin Drug Saf 2009;8:501-6
   PubMed Web of Science ®Google Scholar
• Iskedjian M, Piwko C, Shear NH, et al. Topical calcineurin inhibitors in the treatment of atopic dermatitis: a meta-analysis of current evidence. Am J Clin Dermatol 2004;5:267-79
   PubMed Web of Science ®Google Scholar
• Ashcroft DM, Dimmock P, Garside R, et al. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials. BMJ 2005;330:516
   PubMed Web of Science ®Google Scholar
• Agrup G, Lassus A, Liden S, et al. Ranking of corticosteroid ointments -- an updating. Nord Med 1983;98:294-5
   PubMedGoogle Scholar
• Niedner R. Topically administered glucocorticosteroids. Part 2: Dose effect – preparations. Fortschr Med 1992;110:345
   PubMedGoogle Scholar
• Niedner R. External administration of glucocorticosteroids. Part 1: Administration guidelines – classification. Fortschr Med 1992;110:327-9
   PubMedGoogle Scholar
• British Medical Association and the Royal Pharmaceutical Society of Great Britain. British National Formulary, 57th edn. UK: BMJ Publishing Group, 2009
   Google Scholar
• Conde JF, Kaur M, Fleischer AB Jr, et al. Adherence to clocortolone pivalate cream 0.1% in a pediatric population with atopic dermatitis. Cutis 2008;81:435-41
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org
   Google Scholar
• Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Smith GD, Altman DG, eds., Systematic Reviews in Health Care: Meta-Analysis in Context, 2nd edn. London: BMJ Publishing Group, 2008
   Google Scholar
• Nakagawa H. Comparison of the efficacy and safety of 0.1% tacrolimus ointment with topical corticosteroids in adult patients with atopic dermatitis: review of randomised, double-blind clinical studies conducted in Japan. Clin Drug Invest 2006;26:235-46
   PubMed Web of Science ®Google Scholar
• Doss N, Reitamo S, Dubertret L, et al. Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial. Br J Dermatol 2009;161:427-34
   PubMed Web of Science ®Google Scholar
• Hebert AA, Koo J, Fowler J, et al. Desoximetasone 0.25% and tacrolimus 0.1% ointments versus tacrolimus alone in the treatment of atopic dermatitis. Cutis 2006;78:357-63
   PubMed Web of Science ®Google Scholar
• Mandelin J, Remitz A, Virtanen H, et al. One-year treatment with 0.1% tacrolimus ointment versus a corticosteroid regimen in adults with moderate to severe atopic dermatitis: a randomized, double-blind, comparative trial. Acta Derm Venereol 2010;90:170-4
   PubMed Web of Science ®Google Scholar
• Reitamo S, Rustin M, Ruzicka T, et al. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis. J Allergy Clin Immunol 2002;109:547-55
   PubMed Web of Science ®Google Scholar
• Reitamo S, Harper J, Bos JD, et al. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial. Br J Dermatol 2004;150:554-62
   PubMed Web of Science ®Google Scholar
• Reitamo S, Ortonne JP, Sand C, et al. A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis. Br J Dermatol 2005;152:1282-9
   PubMed Web of Science ®Google Scholar
• Hofman T, Cranswick N, Kuna P, et al. Tacrolimus ointment does not affect the immediate response to vaccination, the generation of immune memory, or humoral and cell-mediated immunity in children. Arch Dis Child 2006;91:905-10
   PubMed Web of Science ®Google Scholar
• Bieber T, Vick K, Folster-Holst R, et al. Efficacy and safety of methylprednisolone aceponate ointment 0.1% compared to tacrolimus 0.03% in children and adolescents with an acute flare of severe atopic dermatitis. Allergy 2007;62:184-9
   PubMed Web of Science ®Google Scholar
• Doss N, Kamoun MR, Dubertret L, et al. Efficacy of tacrolimus 0.03% ointment as second-line treatment for children with moderate-to-severe atopic dermatitis: evidence from a randomized, double-blind non-inferiority trial vs. fluticasone 0.005% ointment. Pediatr Allergy Immunol 2010;21:321-9
   PubMed Web of Science ®Google Scholar
• Gradman J, Wolthers OD. Short-term growth in children with eczema during treatment with topical mometasone furoate and tacrolimus. Acta Paediatr 2007;96:1233-7
   PubMed Web of Science ®Google Scholar
• Torok HM, Maas-Irslinger R, Slayton RM. Clocortolone pivalate cream 0.1% used concomitantly with tacrolimus ointment 0.1% in atopic dermatitis. Cutis 2003;72:161-6
   PubMed Web of Science ®Google Scholar
• Hung S-H, Lin Y-T, Chu C-Y, et al. Staphylococcus colonization in atopic dermatitis treated with fluticasone or tacrolimus with or without antibiotics. Ann Allergy Asthma Immunol 2007;98:51-6
   PubMed Web of Science ®Google Scholar
• Sikder AU, Al Mamun S, Khan RM, et al. Topical 0.03% tacrolimus ointment, 0.05% clobetasone butyrate cream alone and their combination in older children with atopic dermatitis - An open randomized comparative study. J Pak Assoc Dermatol 2005;15:304-12
   Google Scholar
• Breneman D, Fleischer Jr AB, Abramovits W, et al. Tacrolimus ointment with and without topical steroids in patients with moderate to severe atopic dermatitis. J Am Acad Dermatol 2006;54(3, Suppl 1) AB88, Abstr. P832
   Web of Science ®Google Scholar
• Reitamo S. Treatment with tacrolimus ointment significantly improves the quality of life for patients with moderate to severe atopic dermatitis: results of the MOS-36 item short-form health survey. J Eur Acad Dermatol Venereol 2004;18(Suppl 2):162-3, Abstr. FC07.11
   Google Scholar
• Reitamo S. Quality of life improved in adults with moderate to severe atopic dermatitis treated with 0.1% tacrolimus ointment. European Academy of Dermatology and Venereology Spring Symposium, 2004
   Google Scholar
• Darsow U, Lubbe J, Taieb A, et al. Position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol Venereol 2005;19:286-95
   PubMed Web of Science ®Google Scholar
• Wollenberg A, Bieber T. Proactive therapy of atopic dermatitis – an emerging concept. Allergy 2009;64:276-8
   PubMed Web of Science ®Google Scholar
• Wollenberg A, Reitamo S, Girolomoni G, et al. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. Allergy 2008;63:742-50
   Web of Science ®Google Scholar
• Thaci D, Reitamo S, Gonzalez Ensenat MA, et al. Proactive disease management with 0.03% tacrolimus ointment for children with atopic dermatitis: results of a randomized, multicentre, comparative study. Br J Dermatol 2008;159:1348-56
   PubMed Web of Science ®Google Scholar
• Reitamo S, Allsopp R. Treatment with twice-weekly tacrolimus ointment in patients with moderate to severe atopic dermatitis: results from two randomized, multicentre, comparative studies. J Dermatolog Treat 2010;21:34-44
   PubMed Web of Science ®Google Scholar
• Charman C, Chambers C, Williams H. Measuring atopic dermatitis severity in randomized controlled clinical trials: what exactly are we measuring? J Invest Dermatol 2003;120:932-41
   PubMed Web of Science ®Google Scholar
• Schmitt J, Langan S, Williams HC. What are the best outcome measurements for atopic eczema? A systematic review. J Allergy Clin Immunol 2007;120:1389-98
   PubMed Web of Science ®Google Scholar